CAS No 936563-96-1 IBRUTINIB Pharmaceutical Intermediates
Product detail
Ibrutinib is a breakthrough drug that has changed the treatment landscape for various hematological malignancies. As a selective inhibitor of Bruton's tyrosine kinase (BTK), ibrutinib plays a vital role in the treatment of diseases such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Its unique mechanism of action and favorable pharmacokinetic properties make it a valuable asset for the pharmaceutical industry.
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
As a factory integrating production and trading, we are committed to providing high-quality Ibrutinib efficiently and reliably. Our extensive experience in chemical manufacturing enables us to provide products that meet the specific needs of our customers. We prioritize customer satisfaction and work closely with our customers to ensure timely delivery and support throughout the procurement process.
In summary, Ibrutinib is a must-have drug for pharmaceutical companies seeking to enhance their oncology product offerings. With its superior physical and chemical properties, coupled with our commitment to quality and customer service, we are your trusted partner in the pharmaceutical industry. Contact us today to learn more about our products and how we can support your business needs.



